Gainers
- Molina Healthcare MOH stock moved upwards by 24.2% to $503.11 during Wednesday's after-market session. The company's market cap stands at $29.3 billion.
- Evoke Pharma EVOK shares rose 18.54% to $0.76. The market value of their outstanding shares is at $6.4 million.
- Aptorum Gr APM stock rose 11.75% to $4.84. The company's market cap stands at $25.0 million.
- Galecto GLTO shares moved upwards by 10.49% to $0.83. The company's market cap stands at $22.5 million.
- Mira Pharmaceuticals MIRA stock moved upwards by 9.99% to $1.21. The market value of their outstanding shares is at $17.8 million.
- Cyclo Therapeutics CYTH shares increased by 9.87% to $1.78. The company's market cap stands at $50.8 million.
Losers
- Spruce Biosciences SPRB stock declined by 75.2% to $1.29 during Wednesday's after-market session. The market value of their outstanding shares is at $52.5 million.
- Qilian Intl Hldg Gr QLI stock fell 9.1% to $0.59. The market value of their outstanding shares is at $21.0 million.
- NuCana NCNA stock fell 8.58% to $0.38. The market value of their outstanding shares is at $20.2 million.
- Regencell Bioscience RGC stock decreased by 7.9% to $5.6. The market value of their outstanding shares is at $72.8 million.
- Bright Green BGXX shares declined by 7.48% to $0.26. The company's market cap stands at $47.8 million.
- Lipocine LPCN stock declined by 7.1% to $4.45. The company's market cap stands at $23.6 million. The company's, Q4 earnings came out 4 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
APMAptorum Group Ltd
$1.71-2.29%
Edge Rankings
Momentum
33.95
Price Trend
Short
Medium
Long
BGXXBright Green Corp
$0.0380-%
EVOKEvoke Pharma Inc
$4.42-3.70%
GLTOGalecto Inc
$3.75-1.37%
LPCNLipocine Inc
$3.30-0.55%
MIRAMira Pharmaceuticals Inc
$1.750.57%
MOHMolina Healthcare Inc
$164.754.13%
NCNANuCana PLC
$0.060912.8%
RGCRegencell Bioscience Holdings Ltd
$14.93-1.65%
SPRBSpruce Biosciences Inc
$0.117449.4%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.